Here are five highlights:
1. Mr. Wehrly is the CEO of Synaptive Medical. He became CEO in October 2017 and served on the company’s board of directors from 2015 to 2017.
2. Prior to his current position, Mr. Wehrly served as the CEO of PQ Bypass, a developer of peripheral arterial disease treatment technology.
3. Mr. Wehrly spent time as group president of developed markets for Covidien, a medical device manufacturer that was acquired by Medtronic in 2015.
4. Titan Spine is working to expand its nanoLOCK technology, which gained FDA clearance in 2014.
5. Titan Spine offers a full line of Endoskeleton titanium implants that feature its nanoLOCK surface technology.
More articles on surface technology:
3D-printed implants viable for revision lumbar fusion, study shows – 4 insights
Venture capital fund invests in PEEK implant company — 3 things to know
Study says: Nanosurface implant texture increases blood vessel formation, drives bone growth
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
